Showing results 1 to 20 of 43
next >
| Issue Date | Title | Author(s) |
| Oct-2021 | ACUTE VARICEAL BLEEDING PORTENDS POOR OUTCOMES IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE: A PROPENSITY SCORE MATCHED MULTINATIONAL STUDY FROM APASL ACLF RESEARCH CONSORTIUM (AARC) | Agarwal, Samagra; Sharma, Sanchit; Choudhury, Ashok Kumar; Saraya, Anoop; Mahtab, Mamun A.; Saigal, Sanjiv; Kim, Dong Joon; Eapen, C. E.; Goel, Ashish; Ning, Qin; Devarbhavi, Harshad; Singh, Virendra; Duseja, Ajay K.; Verma, Nipun; Shukla, Akash; Hamid, Saeed S.; Butt, Amna S.; Jafri, Syed Muhammad Wasim; Hu, Jinhua; Tan, Soeksiam; Arora, Anil; Kumar, Ashish; Sahu, Manoj Kumar; Rela, Mohamed; Jothimani, Dinesh K.; Rao, Padaki Nagaraja; Kulkarni, Anand V.; Ghazinyan, Hasmik; Lee, Guan Huei; Liu, Shuang; Sood, Ajit; Goyal, Omesh; Midha, Vandana; Lesmana, Laurentius A.; Lesmana, Cosmas Rinaldi; Treeprasertsuk, Sombat; Nan, Yuemin; Shah, Samir; Chen, Tao; Dayal, Vm; Xin, Shaojie; Karim, Fazal; Abbas, Zaigham; Sollano, Jose Decena, Jr.; Kalista, Kemal Fariz, Jr.; Shrestha, Ananta; Payawal, Diana A.; Sarin, Shiv K. |
| 2019 | All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china | Wei, Lai; Xu, Xiaoyuan; Guan, Yujuan; Zheng, Sujun; Sheng, Ji-Fang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Ji-Dong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojong; Zhang, Quan; Hu, Peng; Wang, Fu-Sheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi |
| Feb-2022 | Attitudes of Chinese Patients with Non-alcoholic Fatty Liver Disease Toward Participation in Clinical Trials from a National Multicenter Survey | Huang, Rui; Rao, Huiying; Lv, Fangfang; Nan, Yuemin; Ren, Wanhua; Huang, Yan; Li, Jun; Tang, Hong; Huang, Yuan; Chalasani, Naga; Wei, Lai |
| 2018 | The Attitudes of Patients with Nonalcoholic Fatty Liver Disease Towards Participation in Placebo-Controlled Clinical Trials: Results from a Multicenter Survey | Huang, Rui; Rao, Huiying; Lv, Fangfang; Nan, Yuemin; Ren, Wanhua; Huang, Yan; Li, Jun; Tang, Hong; Huang, Yuan; Chalasani, Naga P.; Wei, Lai |
| 2018 | The Attitudes of Patients with Nonalcoholic Fatty Liver Disease Towards Participation in Placebo-Controlled Clinical Trials: Results from a Multicenter Survey | Huang, Rui; Rao, Huiying; Lv, Fangfang; Nan, Yuemin; Ren, Wanhua; Huang, Yan; Li, Jun; Tang, Hong; Huang, Yuan; Chalasani, Naga P.; Wei, Lai |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| 2018 | Baseline and Treatment Profiles of Patients Recruited in China Registry of Hepatitis B | Shan, Shan; You, Hong; Niu, Junqi; Shang, Jia; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Zhang, Lingyi; Nan, Yuemin; Han, Tao; Wang, Xiaozhong; Liu, Xiaoqing; Dou, Xiaoguang; Xu, Xiaoyuan; Wei, Lai; Hou, Jinlin; Duan, Zhongping; Zhuang, Hui; Kong, Yuanyuan; Jia, Jidong |
| Mar-2020 | China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B | Shan, Shan; Wei, Wei; Kong, Yuanyuan; Niu, Junqi; Shang, Jia; Xie, Wen; Zhang, Yuexin; Ren, Hong; Tang, Hong; Ding, Huiguo; Nan, Yuemin; Dou, Xiaoguang; Han, Tao; Xu, Xiaoyuan; Duan, Zhongping; Wei, Lai; Hou, Jinlin; Zhuang, Hui; You, Hong; Jia, Jidong |
| 9-Jul-2024 | Chinese guidelines on the management of ascites in cirrhosis Chinese Society of Hepatology, Chinese Medical Association | Xu, Xiaoyuan; Ding, Huiguo; Jia, Jidong; Wei, Lai; Duan, Zhongping; Tang, Chengwei; Linghu, Enqiang; Nan, Yuemin; Han, Ying; Xu, Jinghang; Zhuang, Hui |
| 2019 | Complication is a major risk factor for mortality of cirrhotic hepatitis B virus-related acuted-on-chronic liver failure patients: A multi-national study from Asian-pacific region | Chen, Tao; Yang, Zhongyuan; Li, Jun; Han, Tao; Hu, Jinhua; Xin, Shaojie; Choudhury, Ashok; Al-Mahtab, Mamun; Nan, Yuemin; Tan, Soek-Siam; Hamid, Saeed Sadiq; Subhan, Amna; Jafri, Wasim; Lee, Guan Huei; Ghazinian, Hasmik; Chawla, Yogesh; Yuen, Man-Fung; Jia, Ji-Dong; Abbas, Zaigham; Devarbhavi, Harshad; Dokmeci, A. Kadir; Amarapurkar, Deepak; Kumar, Manoj; Lesmana, Laurentius A.; Lau, George; Yokosuka, Osamu; Duan, Zhongping; Guo, Wei; Ma, Ke; Zhang, Zhongwei; Sarin, Shiv Kumar; Ning, Qin |
| Nov-2021 | Consensus on the secondary prevention of primary liver cancer | Nan, Yuemin; Xu, Xiaoyuan; Gao, Yanhang; Wang, Rongqi; Li, Wengang; Yang, Ming; Liu, Lingdi; Duan, Zhongping; Jia, Jidong; Wei, Lai; Zhuang, Hui |
| Jan-2022 | Consensus on the secondary prevention of primary liver cancer (vol 15, pg 1289, 2021) | Nan, Yuemin; Xu, Xiaoyuan; Gao, Yanhang; Wang, Rongqi; Li, Wengang; Yang, Ming; Liu, Lingdi; Duan, Zhongping; Jia, Jidong; Wei, Lai; Zhuang, Hui |
| 2023 | Consensus on the tertiary prevention of primary liver cancer | Nan, Yuemin; Xu, Xiaoyuan; Dong, Shiming; Yang, Ming; Li, Ling; Zhao, Suxian; Duan, Zhongping; Jia, Jidong; Wei, Lai; Zhuang, Hui; Chinese Med Assoc; Chinese Society Hepatology |
| 2019 | Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir | Kong, Yuanyuan; Sun, Yameng; Zhou, Dialing; Wu, Xiaoning; Chen, Yongpeng; Piao, Hongxin; Lu, Lungen; Ding, Huiguo; Nan, Yuemin; Jiang, Wei; Xu, Youqing; Xie, Wen; Li, Hanwei; Feng, Bo; Shi, Guangfeng; Chen, Guofeng; Li, Hai; Zheng, Huanwei; Cheng, Jilin; Wang, Tailing; Liu, Hui; Lv, Fudong; Shao, Chen; Mao, Yimin; Sun, Jihong; Chen, Tao; Han, Tao; Han, Ying; Wan, Lin; Ou, Xiaojuan; Zhang, Hui; Jia, Jidong; You, Hong |
| 2018 | Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China | Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei |
| 2018 | Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China | Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei |
| 2019 | Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naive Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China | Xu, Xiaoyuan; Feng, Bo; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; Anl, Ping; Gong, Guozhong; Liu, Huimin; Nine, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, Fusheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi J.; Wei, Lai |
| 2019 | THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL | Wei, Lai; Xu, Xiaoyuan; Zheng, Sujun; Guan, Yujuan; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qing; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang, Sr.; Chen, Liang; Ye, Yinong, Sr.; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi |
| Feb-2023 | Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021) | You, Hong; Duan, Weijia; Li, Shuxiang; Lv, Tingting; Chen, Sha; Lu, Lungen; Ma, Xiong; Han, Ying; Nan, Yuemin; Xu, Xiaoyuan; Duan, Zhongping; Wei, Lai; Jia, Jidong; Zhuang, Hui |
| Jul-2021 | HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation | Xie, Yandi; Li, Minghui; Ou, Xiaojuan; Zheng, Sujun; Gao, Yinjie; Xu, Xiaoyuan; Yang, Ying; Ma, Anlin; Li, Jia; Huang, Yuan; Nan, Yuemin; Zheng, Huanwei; Feng, Bo |
